Brazil Veterinary Vaccines Market To Reach $1.77 Billion By 2030

Brazil Veterinary Vaccines Market Growth & Trends

The Brazil veterinary vaccines market size is estimated to reach USD 1.77 billion by 2030, expanding at a CAGR of 9.70% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors, such as increasing livestock population and mandatory vaccination, are propelling the growth of this market.

Growing prevalence of zoonotic diseases is further boosting the demand for vaccines. Favorable environment and increasing livestock population are among few factors that attract foreign companies to invest in the Brazil market. According to OECD, Brazil received about USD 62.7 billion in Foreign Direct Investment (FDI) in 2018. Foreign animal health companies also entered into the market by acquiring top regional companies. The aforementioned factors are expected to propel the market growth over the forecast period.

The massive outbreak of COVID-19 in countries, such as China and U.S., is expected to boost the growth of the Brazil’s meat export market. For instance, the Brazilian livestock production is expected to increase by nearly 5% due to the COVID-19 pandemic. China already increased its import of meat in 2019 due to the outbreak of African swine fever, which reduced its hog population.

 Request a free sample copy or view report summary: Brazil Veterinary Vaccines Market Report

Brazil Veterinary Vaccines Market Report Highlights

• Live attenuated segment led the global market in 2024. The dominance can be attributed to increased usage of this vaccines in mass vaccination

• On basis of animal type, ruminants held the largest revenue share in 2024 owing to increasing livestock population in the country and new product launches

• For instance, in April 2019, Vetoquinol SA acquired Clarion Biociências, a Brazilian veterinary laboratory, to expand its business in Brazil.

• Boehringer Ingelheim acquired Merial in 2017 to increase its market penetration in Brazil. In 2017, MSD Animal Health acquired Vallée to boost its vaccine portfolio

Brazil Veterinary Vaccines Market Segmentation

Grand View Research has segmented the brazil veterinary vaccines market based on animal type, product, route of administration, and distribution channel:

Brazil Veterinary Vaccines Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Production Animals

  • Poultry

  • Swine

  • Cattle

  • Sheep & Goats

  • Others

• Companion Animals

  • Dogs

  • Cats

  • Horses

  • Others

Brazil Veterinary Vaccines By Product Outlook (Revenue, USD Million, 2018 - 2030)

• Attenuated Live Vaccines

• Inactivated Vaccines

• Subunit Vaccines

• DNA Vaccines

• Recombinant Vaccines

• Autogenous Vaccines

Brazil Veterinary Vaccines By Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Subcutaneous

• Intramuscular

• Intranasal

Brazil Veterinary Vaccines By Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Retail

• E-commerce

• Hospital/ Clinic Pharmacies

List of Key Players in Brazil Veterinary Vaccines Market

• Merck & Co., Inc.

• Elanco

• Boehringer Ingelheim GmbH

• Ceva Santé Animale

• Zoetis

• Biogénesis Bagó S.A.

• Phibro Animal Health Corporation

• Ourofino Saúde Animal

• Dechra Pharmaceuticals Plc (EQT)